We serve Chemical Name:(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine CAS:1223404-88-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine](https://a.dearchem.com/CAS2/1223404-88-3.png)
Chemical Name:(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine
CAS.NO:1223404-88-3
Synonyms:(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine
Molecular Formula:C16H15F2N5
Molecular Weight:315.3206064
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.50±0.1 g/cm3
Index of Refraction:
PSA:
Exact Mass:
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine Use and application,(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine technical grade,usp/ep/jp grade.
Related News: In SLE, along with the pivotal TULIP phase III programme, anifrolumab continues to be evaluated in a long-term extension phase III trial.12 A phase II trial of anifrolumab in SLE using subcutaneous delivery has been completed. Peptide,(Ser-Ser-Pro-Pro-Xaa-Xaa-Xaa-Pro-Pro-Pro-Ile-Pro-Asn-Ser-Pro-Gln-Val-Leu-Ser-Arg) manufacturers “Slower growth in China is no question,” AstraZeneca CEO Pascal Soriot told investors on the call. “We believe we can continue growing [and] maintain our position of leadership, but it’s going to be more difficult moving forward.” 6-Ethoxy-2-methyl-4-thiophen-2-yl-4,5-dihydro-pyrimidine-5-carboxylic acid ethyl ester suppliers Biogen’s top research chief, Dr. Al Sandrock, defended the drug in an open letter released alongside the company’s earnings Thursday, saying its approval has been subject to “extensive misinformation and misunderstanding.” alanyl-proline-p-bromo-anilide vendor & factory.
